Iris H I M Hollink
Overview
Explore the profile of Iris H I M Hollink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Balgobind B, van den Heuvel-Eibrink M, de Menezes R, Reinhardt D, Hollink I, Arentsen-Peters S, et al.
Haematologica
. 2010 Oct;
96(2):221-30.
PMID: 20971820
Background: Pediatric acute myeloid leukemia is a heterogeneous disease characterized by non-random genetic aberrations related to outcome. The genetic subtype is currently detected by different diagnostic procedures which differ in...
22.
Hollink I, van den Heuvel-Eibrink M, Zimmermann M, Balgobind B, Arentsen-Peters S, Alders M, et al.
J Clin Oncol
. 2010 Jul;
28(28):e523-6.
PMID: 20644087
No abstract available.
23.
Bachas C, Schuurhuis G, Hollink I, Kwidama Z, Goemans B, Zwaan C, et al.
Blood
. 2010 Jul;
116(15):2752-8.
PMID: 20592250
Although virtually all pediatric patients with acute myeloid leukemia (AML) achieve a complete remission after initial induction therapy, 30%-40% of patients will encounter a relapse and have a dismal prognosis....
24.
Balgobind B, Hollink I, Reinhardt D, van Wering E, De Graaf S, Baruchel A, et al.
Eur J Cancer
. 2010 Mar;
46(10):1892-9.
PMID: 20233657
Mixed-lineage leukaemia (MLL)-partial tandem duplications (PTDs) are found in 3-5% of adult acute myeloid leukaemia (AML), and are associated with poor prognosis. In adult AML, MLL-PTD is only detected in...
25.
Hollink I, van den Heuvel-Eibrink M, Zwaan C
Blood
. 2009 Jun;
113(26):6501-2.
PMID: 19556429
No abstract available.
26.
Hollink I, van den Heuvel-Eibrink M, Zimmermann M, Balgobind B, Arentsen-Peters S, Alders M, et al.
Blood
. 2009 Jan;
113(23):5951-60.
PMID: 19171881
Wilms tumor 1 (WT1) mutations have recently been identified in approximately 10% of adult acute myeloid leukemia (AML) with normal cytogenetics (CN-AML) and are associated with poor outcome. Using array-based...